Derma medicine company helps to find contact details of the top derma medicine PCD Company who are offering PCD Pharma Franchise for derma or skincare products. all our listed Derma medicine PCD companies provide monopoly right for a wide range of high-quality dermatology products Like us deals in medicine and tablets, capsules, dusting powders, cream, ointments, gels, shampoo, lotions, etc. Apart from that, the platform is also used by the PCD Dermafranchise company and Third Party Derma PCD Manufacturing Companies to invite
Derma products distributors to get Derma PCD pharma franchise opportunity in the pan India locations.
Med Health Pharmaceuticals providing the cash- strapped health care system around the world struggling and call on pharmaceutical healthcare provider companies for new innovation with pharma healthcare.
pharma healthcare, pharmaceutical healthcare, healthcare pharmacy, health science pharmacy, health online pharmacy, healthcare pharmacy, health pharmacy near me, pharma healthcare, pharmaceutical health, health lane pharmacy, health department pharmacy.
click here to know more:- Med Health Pharmaceuticals
The global gastrointestinal therapeutics market size is expected to reach USD 65.1 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period.
Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth.
According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014.Growing geriatric population, especially in emerging economies, is expected to drive market growth over the coming years.
Furthermore, initiatives undertaken by the Centers for Disease Control and Prevention (CDC) to promote cancer screening nationwide is expected to boost market growth over the forecast period.
The Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign (NCCCP) and provides funds to aid research studies and implement strategies to control colorectal cancer.
This increase in initiatives for screening is expected to fuel sales of therapeutics and present lucrative growth opportunities to the market.Further key findings from the report suggest:Based on product type, the branded drugs segment dominated in 2016 owing to high potency drugs such as biologics and proton pump inhibitors.